髋关节Perthes病结局指标:核心结局集开发研究方案
本研究方案旨在为Perthes病干预研究制定核心结局集(COS)。方法包括系统综述现有文献中的结局、访谈患儿及家长补充结局、两轮Delphi调查评估重要性,以及共识会议确定最终COS。目标是标准化未来研究结局,促进研究间比较与荟萃分析。
要点
- Perthes病干预研究缺乏标准化结局,导致研究间难以比较。
- 将通过系统综述、患者访谈、两轮Delphi调查和共识会议制定COS。
- COS旨在规范未来临床试验的结局测量与报告,促进证据合成。
核心结论
- 制定Perthes病核心结局集(COS)以标准化未来研究结局,便于比较和荟萃分析。
研究设计与样本
- 研究方案:系统综述文献、访谈患儿/成人患者/家长、两轮Delphi调查、共识会议。
关键数值与推荐
- Delphi调查分两轮评估结局重要性,最终共识会议确定COS。
临床怎么用
- 未来Perthes病临床试验应测量和报告COS规定的核心结局变量。
局限性
- 方案阶段,尚未报告实际形成的COS内容及共识结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perthes' disease is an idiopathic osteonecrosis of a developmental hip that is most frequent in Northern Europe. Currently, the absence of a common set of standardised outcomes makes comparisons between studies of different interventions challenging. This study aims to summarise the outcomes used in clinical research of interventions for Perthes' disease and define a set of core outcomes (COS) to ensure that the variables of primary importance are measured and reported in future research studies investigating Perthes' disease. METHODS: A systematic review of the current literature will be used to identify a list of outcomes reported in previous studies. Additional important outcomes will be sought by interviewing a group of children with Perthes' disease, adults who were treated with the disease in infancy and parents of children with the disease. This list will then be evaluated by experts in Perthes' disease using a Delphi survey divided into two rounds to ascertain the importance of each outcome. The final outcomes list obtained from the Delphi survey will be then discussed during a consensus meeting of representative key stakeholders in order to define the COS to be reported in future clinical trials related to Perthes' disease. DISCUSSION: The absence of high-quality research and clear guidelines concerning the management of Perthes' disease is, at least in part, due to the difficulties in the comparing the results from previous studies. The development of a COS seeks to standardise outcomes collected in future research studies to enable comparisons between studies to be made and to facilitate meta-analyses of results. TRIAL REGISTRATION: Core Outcome Measures in Effectiveness Trials Initiative (COMET), 1003 . Registered on 20 July 2017. Prospero International Prospective Register of Systematic Reviews, CRD 42017069742 . Registered on 10 July 2017.
引用
- Leo DG, Leong WY, Gambling T, et al. The outcomes of Perthes' disease of the hip: a study protocol for the development of a core outcome set. Trials. 2018. PMID: 30005667. doi:10.1186/s13063-018-2695-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。